Literature DB >> 26445390

Tick-borne Relapsing Fever in Children in the North-west of Iran, Qazvin.

Parviz Ayazi1, Abolfazl Mahyar2, Sonia Oveisi3, Neda Esmailzadehha3, Sadralnesa Nooroozi2.   

Abstract

Relapsing fever is caused by the Borrelia species of spirochetes. Louse-borne epidemics of the disease may happen but the endemic disease is generally transmitted to humans by the bite of an infected tick (Ornithodorus). Clinical and laboratory findings of tick-borne relapsing fever in children in the north-west of Iran, Qazvin, were evaluated. This study was conducted from September 1992 to September 2012. Records from 53 cases of tick-borne relapsing fever (TBRF) were reviewed. In positive cases, febrile illness, and spirochetes were recognized in peripheral blood preparations. Of the 53 children younger than 12 years, fifty two percent were male and about one third (34%) of the patients were in the age range of 7-12 years. The disease is recorded through the whole year but its peak occurs during summer (52.8%) and autumn (32.1%). Sixty eight percent of patients were living in urban areas but had frequent travel to rural area. Thirty two percent of the cases were living in rural areas where their dwellings were close to animal shelters. All (100%) of the 53 subjects were febrile. Travellers to the rural areas with high prevalence of the disease should be attentive of the risk of tick-borne relapsing fever and use suitable control measures. Consequently relapsing fever should be considered when patients who live in or have vacationed in north-west of Iran show a recurring febrile illness.

Entities:  

Keywords:  <i>Borrelia</i>; Children; Clinical; Laboratory; Tick-borne relapsing fever (TBRF)

Mesh:

Substances:

Year:  2015        PMID: 26445390     DOI: 10.14712/23362936.2015.58

Source DB:  PubMed          Journal:  Prague Med Rep        ISSN: 1214-6994


  1 in total

1.  Tickborne Relapsing Fever, Jerusalem, Israel, 2004-2018.

Authors:  Saar Hashavya; Itai Gross; Matan Gross; Noa Hurvitz; Giora Weiser; Violeta Temper; Orli Megged
Journal:  Emerg Infect Dis       Date:  2020-10       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.